Back
iShares 0-5 Year High Yield Corp Bd ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
40
SHYG
iShares 0-5 Year High Yield Corp Bd ETF
Last Price:
42.96
Seasonality Move:
-0.03%
Sell
39
HALO
Halozyme Therapeutics
Last Price:
45.65
Seasonality Move:
17.03%
Sell
40
iShares 0-5 Year High Yield Corp Bd ETF (SHYG)
is a Sell
Is iShares 0-5 Year High Yield Corp Bd ETF a Buy, Sell or Hold?
- The current iShares 0-5 Year High Yield Corp Bd ETF [SHYG] share price is $42.97. The Score for SHYG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- SHYG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SHYG Stock Price Chart
What is iShares 0-5 Year High Yield Corp Bd ETF's stock price today?
-
The iShares 0-5 Year High Yield Corp Bd ETF share price today is $42.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SHYG is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
SHYG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 46.88 | Sell |
Chaikin Money Flow: | 1315605 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.91 - 43.15) | Sell |
Bollinger Bands (100): | (42.47 - 43.17) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 30.2 | Sell |
Chaikin Money Flow: | -7140517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.94 - 58.56) | Sell |
Bollinger Bands (100): | (52.16 - 60.38) | Sell |
SHYG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.08 | Sell |
20-day SMA: | 43.01 | Sell |
50-day SMA: | 43.09 | Sell |
200-day SMA: | 42.51 | Buy |
8-day EMA: | 43.03 | Sell |
20-day EMA: | 43.03 | Sell |
50-day EMA: | 43 | Sell |
200-day EMA: | 42.55 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.53 | Sell |
20-day SMA: | 54.48 | Sell |
50-day SMA: | 56.18 | Sell |
200-day SMA: | 48.93 | Sell |
8-day EMA: | 55 | Sell |
20-day EMA: | 55.41 | Sell |
50-day EMA: | 55.64 | Sell |
200-day EMA: | 50.73 | Sell |
iShares 0-5 Year High Yield Corp Bd ETF Earnings Growth & SHYG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.
iShares 0-5 Year High Yield Corp Bd ETF Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |